PMVP 8-K: SEC filing
PMV Pharmaceuticals, Inc.
Filed with the SEC on · accession 0001193125-26-454467
PMVP filed a 8-K (current report) with the SEC on Nov 10, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved -2.0% by the first close after the filing.
Summary of the filing
PMV Pharmaceuticals, Inc. issued a press release announcing its financial results for the third quarter ended September 30, 2026, furnished under Item 2.02 of Form 8-K.
Key details
How PMVP stock reacted
Close before
$1.25
Nov 9, 2026
First close after
-2.00%
$1.23
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for PMVP, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for PMVP?
Click hereFrequently asked questions
What did PMVP file with the SEC on Nov 10, 2026?
PMVP filed a 8-K (SEC filing). PMV Pharmaceuticals, Inc. issued a press release announcing its financial results for the third quarter ended September 30, 2026, furnished under Item 2.02 of Form 8-K.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
How did PMVP stock react to this filing?
PMVP closed at $1.25 before the filing and $1.23 on Nov 10, 2026 (-2.00%).
Other PMVP SEC filings
- 10-Q · SEC filingNov 10, 2026
- 8-K · Board changeOct 5, 2026
- 424B5 · Secondary offeringSep 2, 2026
- 8-K · Secondary offeringSep 2, 2026
- 424B3 · Secondary offeringAug 31, 2026
- 424B5 · Secondary offeringAug 31, 2026
- 8-K · Fda approvalAug 31, 2026
- 10-Q · SEC filingAug 14, 2026
- 8-K · SEC filingAug 14, 2026
- 8-K · Board changeJun 5, 2026
Get alerts when PMVP files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days